InvestorsObserver
×
News Home

Can Soleno Therapeutics Inc (SLNO) Stock Rise to the Top of Healthcare Sector Friday?

Friday, November 03, 2023 10:36 AM | InvestorsObserver Analysts

Mentioned in this article

Can Soleno Therapeutics Inc (SLNO) Stock Rise to the Top of Healthcare Sector Friday?

The 92 rating InvestorsObserver gives to Soleno Therapeutics Inc (SLNO) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 97 percent of stocks in the Healthcare sector, SLNO’s 92 overall rating means the stock scores better than 92 of all stocks.

Overall Score - 92
SLNO has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on SLNO!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 92 means the stock is more attractive than 92 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Soleno Therapeutics Inc Stock Today?

Soleno Therapeutics Inc (SLNO) stock is trading at $23.95 as of 10:34 AM on Friday, Nov 3, an increase of $0.18, or 0.76% from the previous closing price of $23.77. The stock has traded between $23.52 and $25.64 so far today. Volume today is light. So far 73,443 shares have traded compared to average volume of 2,276,263 shares. Click Here to get the full Stock Report for Soleno Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App